baber/WOPTO huggingface dataset:
Patent NZ-223912-A (NZ)
Title: Device for drawing cables into conduit
Inventor: KUMPF ERICH
IPC: H02G1/08
Filed: 1988-03-16
Abstract: PCT No. PCT/EP88/00210 Sec. 371 Date Nov. 16, 1989 Sec. 102(e) Date Nov. 16, 1989 PCT Filed Mar. 16, 1988 PCT Pub. No. WO88/07281 PCT Pub. Date Sep. 22, 1988.A device for retrospectively drawing cables into cable protection pipes which are already provided with at least one cable. The device includes an elongated partition floor inserted into the protection pipes. The partition has a central region having an upper and a lower surface. On both sides of the partition, transverse to the central region, there is provided a hollow tubular longitudinal edge which determines the level of the partition floor in the protection pipes. The central region is provided at at least one of the upper and lower surfaces with at least one reinforcing rib extending in the longitudinal direction of the partition floor.
Patent NZ-224050-A (NZ)
Title: Non-woven fabric with longitudinal yarns connected by polymeric material and method of manufacture
Inventor: LEFKOWITZ LEONARD ROBERT
IPC: D21F7/08
Filed: 1988-03-28
Abstract: This invention concerns a nonwoven fabric having knuckle-free planar surfaces comprising parallel linear machine direction yarns (10) residing in a single plane and interconnecting, cross-machine direction polymeric material (18) also residing in said plane and substantially entirely surrounding the machine direction yarns (10), the cross-machine direction material containing spaced apertures in the fabric. The invention is also directed to the method of producing such a nonwoven fabric.
Patent NZ-224110-A (NZ)
Title: Antistatic and electrically conducting polyer compositions and the charge transfer compound used therein
Inventor: FINTER J
IPC: C08K5/45
Filed: 1988-03-31
Abstract: The reaction of electron acceptors, such as, for example, chlorine, bromine and/or iodine with compositions containing a linear, branched or structurally crosslinked polymer and a substituted or unsubstituted tetrathio-, tetraseleno- or tetratelluronaphthalene or -tetracene gives the compositions electric conductivity as a result of the formation of charge-transfer complexes. These compositions are suitable for producing antistatically finished or electrically conductive moulded articles, films, filaments, fibres, coatings and composites.
Patent NZ-226788-A (NZ)
Title: Chewing gum containing a twice-coated high potency sweetener, and preparation thereof
Inventor: ZIBELL STEVEN E
IPC: A23L27/00
Filed: 1988-10-31
Abstract: The present invention is a method for producing a chewing gum with a delayed release high-potency sweetener as well as the chewing gum so produced. The delayed release high-potency sweetener is obtained by mixing a quantity of previously coated high-potency sweetener particles with a limited quantity of a solution of zein. Preferably, the zein is dissolved in water with a pH between about 11.5 and about 12.1. The quantity of the zein solution being added is limited to thereby produce a damp mix which is characterized as being dust free, non-flowing, and crumbly. The damp mix is dried and then particle sized to thereby produce twice-coated particles of the high-potency sweetener within a predetermined particle size range. When incorporated into the chewing gum, these particles are adapted to enhance the shelf-stability of the sweetener and/or produce a delayed release when the gum is chewed.
Patent NZ-226872-A (NZ)
Title: Production of 2,3'-anhydro-2'-deoxyuridine derivatives
Inventor: REESE C B
IPC: C07H19/073
Filed: 1988-11-07
Abstract: A process for the production of a 5-substituted derivative of a 2,3 min -anhydro-2 min -deoxyuridine preferably corresponding to the following general formula: <CHEM>  wherein  R<1> represents H, alkyl, aryl, halogeno or CF3; characterised in that it comprises heating a 5-substituted derivative of a 2 min -deoxyuridine preferably corresponding to the following general formula: <CHEM>  wherein R<1> is as defined above; in the presence of a sulphite transfer reagent and preferably a solvent is disclosed. This process improves the production of valuable intermediates and hence facilitates and reduces the cost of production of pharmacologically-interesting compounds.
Patent NZ-229354-A (NZ)
Title: Treating polymer surfaces with a gas plasma and then applying a layer of endothelial cells to the surface
Inventor: WILLIAMS JOEL L
IPC: A61L33/00
Filed: 1989-05-31
Abstract: Small diameter plastic tubing is plasma-treated on the lumen wall and endothelial cells are adhered thereto to give antithrombogenic small diameter conduits useful for vascular grafts and other articles intended to come in contact with blood.
Patent NZ-238657-A (NZ)
Title: Extrudable bonding resin composition comprising at least two different ethylene copolymers having at least one comonomer in common, and a tackifying resin; laminates having these compositions as bonding agent
Inventor: LEE I-HWA
IPC: C09J123/26
Filed: 1991-06-21
Abstract: An extrudable bonding resin composition of (a) 65 to 99 percent of an ethylene copolymer portion of a copolymer of ethylene and 20 to 50 percent comonomer of acids, esters, and the like, and grafted sidechains of comonomer units selected from carboxylic acid, anhydride, salt, or half ester functionality, and optionally a compatible non-grafted ethylene copolymer, and (b) 1 to 35 percent by weight of a tackifying resin exhibits good adhesion properties without the need for a primer.
Patent NZ-240618-A (NZ)
Title: Hydrogen-bridge-bound complexes having 1:1 stoichiometric proportion of an s(+)-phenyl alkane acid and an alpha-hydroxyalkane carboxylic acid; preparatory processes and pharmaceutical compositions
Inventor: PARADIES HENRICH HASKO
IPC: C07C59/08
Filed: 1991-11-15
Abstract: Complexes containing S(+)-ibuprofen, method for the production of these complexes and pharmaceutical preparations containing these complexes are described.
Patent NZ-253862-A (NZ)
Title: Dispensing package having a laterally extending shear depression in the package overlay
Inventor: SEVERIN JANE E
IPC: B65D75/36
Filed: 1993-05-28
Abstract: A dispensing package assembly useful for dispensing a predetermined amount of a fluent material comprises a relatively stiff base sheet, a blister overlay appended to the overlay and a dispenser pouch housed within the confines of the overlay and the sheet. The blister overlay having a main cavity and a secondary cavity includes a dispenser depression, preferably in the shape of a thumb indention, which protrudes downward into the main cavity. A shearing depression extending laterally through the secondary cavity defines an area of reduced depth within the secondary cavity. The main body of the pouch is located within the overlay main cavity having a dispensing channel or passageway extending therefrom beneath the shearing depression and into the secondary cavity.
Patent NZ-295947-A (NZ)
Title: Bioadhesive polymer medicament containing a cross-linked polycarboxylic polymer and an anti-std agent such as nonoxyl-9
Inventor: BOLOGNA WILLIAM JOSEPH
IPC: A61K47/32
Filed: 1995-10-06
Abstract: The present invention provides a composition and use of a composition comprising a bioadhesive cross-linked polycarboxylic acid polymer formulation that enables the use of relatively low mounts of anti-STD infectants, such as N-9, to be used to prevent infection by STDs without causing the irritation to genital tissue that often accompanies higher doses of anti-STDs. The bioadhesive polymer maintains greater contact between the anti-STD agent and the infectant for a much greater period of time, enabling a lower concentration to act longer on the infectant, when compared to currently-available commercial applications containing N-9. Such delivery will enable a safe and non-irritating decrease in the risk of infection with STDs, including HIV.
Patent NZ-329912-A (NZ)
Title: Improved coatings that include a solvent system a wax a UV light absorber and a free radical scavenger to improve resistance of a protective barrier coat to graffiti and other soilings
Inventor: PERLMAN DANIEL
IPC: B05D7/24
Filed: 1997-07-11
Abstract: A method for removing soiling and graffiti markings from a barrier coat, with constituents selected from mineral waxes, synthetic waxes and silicates, previously formed on an underlying surface  preserves rather than sacrifices the barrier coat. The method includes applying a solvent system which includes at least one substantially non-toxic organic solvent such as 1-methyl-2-pyrrolidinone, which dissolves the markings and soiling without dissolving the constituent of the barrier coat to an area of the barrier coat. A method is also provided to improve the resistance of a protective barrier coat to graffiti markings and other soiling over time and thereby facilitate any necessary cleaning of this barrier coat. The improvement in the case of wax coatings is achieved by including in the wax, at least one protective chemical agent selected from the group consisting of wax-soluble/water-insoluble UV light absorbers, wax-soluble/water-insoluble free-radical and peroxy-radical scavengers, and wax-soluble/water-insoluble wax antioxidants. The improvement in the case of silicate coatings is achieved by including in the coating material, an anionic or non-ionic surfactant which improves the adhesion, cohesion, and durability of the barrier coat, and which is compatible with aqueous silicate solutions and emulsions.
Patent NZ-330535-A (NZ)
Title: Display object holder having groove for display object such as a seed packet
Inventor: EASON ANDREW
IPC: G09F23/00
Filed: 1998-05-28
Abstract: resiliently flexible display object 4 in combination with a display object holder 1, has a hole 5 with a border 6 which forms an internal edge to the display object 4.  Display object holder 1 has a body with a relatively small transverse extent and an end 2 which can be inserted through hole 5 in display object 4.  Display object holder 1 has at least one groove 3 in its surface, angled obliquely to both the longitudinal and transverse directions of display object holder 1, located near end 2.  By stretching hole 5 in display object 4, the end of display object holder 1 may be passed through hole 5 until the internal edge of display object 4 is seated in groove 3 in display object holder 1 to locate display object 4 at a predetermined angle relative to display object holder 1.
Patent NZ-332413-A (NZ)
Title: Use of interleukin-10 and an antigen or an CD-3 antibody to inhibit an antigen specific immune response
Inventor: RONCAROLO MARIA-GRAZIA
IPC: A61K38/00
Filed: 1997-05-02
Abstract: Interleukin-10 (IL-10) in combination with an antigen or with an anti CD-3 antibody is used in the manufacture of a medicament for inhibiting an antigen-specific response including antigen-specific responses to subsequent presentation of the antigen by an immune system.  Also disclosed is a population of cells wherein at least 40% of the cells are T-cells that exhibit antigen-specific anergy to an antigen.  The T-cells are further characterized by production upon re-stimulation with the antigen of low IL-2, low IL-5, intermediate IFN-g, low GM-CSF and high IL-10.  The production of IL-2, IL-5, IFN-g, GM-CSF and IL-10 is assayed when the T-cells are cultured in vitro in Yssel's medium supplemented with 10% FCS and 1% human serum.  The production of: a)	IL-2 is less than 500 pg/106 T-cell/ml; b)	IL-5 is between 300 and 3000 pg/106 T-cell/ml; c)	IFN-g is at least 1000 pg/106 T-cell/ml; d)	GM-CSF is 300 to 3000 pg/106 T-cell/ml; and e)	IL-10 is at least 3000 pg/106 T-cell/ml.  The antigen is a protein antigen, particulate antigen, alloantigen or a MHC associated antigen.
Patent NZ-332588-A (NZ)
Title: Cancer antigens CA125 (multiple epitote) recognised by OC125, M11, B43.13, B27.1, where B43.13 is used as a binding agent to elicit host immune response as a vaccination method against cancer
Inventor: MADIYALAKAN RAGUPATHY
IPC: A61K39/395
Filed: 1996-05-15
Abstract: A therapeutic composition for initiating and/or enhancing an immune response by contacting a binding reagent specific for a first epitote on a multi-epitopic in vivo soluble antigen in the host's serum, which the antigen does not elicit a host immune response, wherein the binding agent present is present in the composition that is non-radiolabelled. The binding agent specifically binds to a first epitote on the antigen and forms a binding agent/antigen pair, whereby a host immune response is elicited against a second epitote on the antigen. The composition is useful for the protection from cancer.
Patent NZ-334137-A (NZ)
Title: Single-use syringe, plunger retained within nozzle by detent after use
Inventor: KASHMER JAMES S
IPC: A61M5/32
Filed: 1997-07-16
Abstract: A single use syringe having a plunger that includes an extension (36). The tip of the extension has a detent (62). When the syringe is operated, the extension (36) moves into a nozzle (24) at the needle end of the syringe. The nozzle opening has a resilient locking ring. The locking ring is pushed outwards by the passage of the detent (62), and after the detent has passed, snaps into a groove (30) immediately behind the detent (62). This prevents the plunger being withdrawn to reuse the syringe. The resilient locking ring provides extra resistance that warns the user that the plunger is about to be locked in place. This prevents inadvertent locking of the syringe, for example, when filling.
Patent NZ-335926-A (NZ)
Title: Point of sale system allowing consumers to save or donate when a transaction takes place
Inventor: BURKE BERTRAM V
IPC: G06Q20/04
Filed: 1996-04-25
Abstract: A system (see Figure 1 for structural system, Figures 4 and 5 for system of business operation) and its use for consumer payors to save and donate whenever they use cash at a point of sale terminal (Figure 1, RTI through RTN), write a check, use an ATM machine, or use a credit or debit card. The POS system is a network composed of subscriber/payors, neutral merchant/collectors, a central clearinghouse, and provider accounts. The rounder system is a network composed of subscriber/payors, payees, account managers, and provider services. The systems together provide subscriber/payors with a seamless way to save/donate every time they spend.
Patent NZ-336204-A (NZ)
Title: Treatment of pulp with a chelating agent without using a bleaching tower
Inventor: GERMGARD ULF
IPC: D21C9/10
Filed: 1997-11-06
Abstract: A method of chlorine-free bleaching pulp where metals are removed by means of chelating agent. The chelating agent is mixed with the pulp in at least one effective mixing step without intermediate washing, whereafter the pulp without an intermediate tower passes directly to a pulp washer. The total retention time shall be at maximum 15 minutes, calculated after the chelating agent addition.
Patent NZ-336230-A (NZ)
Title: Heat stable mutants of starch biosynthesis enzymes
Inventor: HANNAH L CURTIS
IPC: C12N15/29
Filed: 1997-11-18
Abstract: The subject invention pertains to novel mutant polynucleotide molecules that encode enzymes that have increased heat stability. These polynucleotides, when expressed in plants, result in increased yield in plants grown under conditions of heat stress. The polynucleotide molecules of the subject invention encode maize endosperm ADP glucose pyrophosphorylase (AGP) and soluble starch synthase (SSS) enzyme activities. Plants and plant tissue bred to contain, or transformed with, the mutant polynucleotides, and expressing the polypeptides encoded by the polynucleotides, are also contemplated by the present invention. The subject invention also concerns methods for isolating polynucleotides and polypeptides contemplated within the scope of the invention. Methods for increasing yield in plants grown under conditions of best stress are also provided.
Patent NZ-336666-A (NZ)
Title: An adhesive binder for bonding together lignocellulosic particles to form fiber boards, and process for preparation
Inventor: VIIKARI LIISA
IPC: C09J197/02
Filed: 1998-01-14
Abstract: n adhesive binder for bonding together lignocellulosic particles, fibers and flakes of vegetable origin to form particle boards, fiber boards, flake boards and similar wood-based products, comprising a solubilized fraction obtained by enzymatic treatment of fibrous, lignocellulosic raw materials. The present binder can be obtained by treating fibrous lignocellulosic raw material with a hydrolytic enzyme in an aqueous medium, recovering the solubilized material of the enzymatic treatment, forming an aqueous suspension containing said material and an oxidase, and oxidizing said material in the presence of said oxidase by introducing oxygen-containing gas into the suspension. This method thus produces an increased amount of a water-soluble fraction containing carbohydrates, extractives and lignin useful as an adhesive binder.
Patent NZ-502181-A (NZ)
Title: Triazole compounds and the use thereof as dopamine-D 3-ligands
Inventor: STARCK DOROTHEA
IPC: C07D401/12
Filed: 1998-07-03
Abstract: Triazole compounds of formula (I) and (VIII), wherein: Ar1 is an optionally substituted aryl or heteroaryl ring that may be fused to a phenyl ring; A is an alkylene optionally interrupted with a group selected from O, S, NR2, CONR2, COO, CO, a double bond and a triple bond; B is a 6 or 7 membered non-aromatic ring containing 1 or 2 nitrogen atoms; and Ar2 is selected from optionally substituted phenyl, pyridyl, pyrimidinyl or triazinyl. The compounds exhibit high dopamine-D3-receptor affinity.
Patent NZ-504199-A (NZ)
Title: Stable chiral compositions comprising 5% to 65% by weight of (R)2-amino-2,3-dimethylbutyronitrile and a water free non-polar solvent
Inventor: GASTROCK WILLIAM HENRY
IPC: C07C255/24
Filed: 2000-04-27
Abstract: A stable composition comprises 5 to 65% by weight of (R)-2-amino-2,3-dimethylbutronitrile and a substantially water free non-polar solvent selected from aromatic hydrocarbons, halogenated aromatic hydrocarbons, hydrocarbons, halogenated hydrocarbons, esters and ethers.
Patent NZ-504395-A (NZ)
Title: Down regulation of endogenous 4-coumarate Co-enzyme A ligase (4CL) in the quaking aspen (Populus tremuloides)
Inventor: CHIANG VINCENT LEE
IPC: C12N9/00
Filed: 1998-11-12
Abstract: Described are methods of altering growth, lignin content, coniferyl and sinapyl alcohol units in the lignin structure, disease resistance and cellulose content in plants.  The methods comprise transformation with a lignin pathway p-coumarate Co-enzyme A ligase (4CL) nucleic acid.
Patent NZ-506317-A (NZ)
Title: 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists for treating gastrointestinal disorders
Inventor: CAROON JOAN MARIE
IPC: A61P13/00
Filed: 1999-02-19
Abstract: Muscarinic receptor antagonists compounds of formula (I), their pharmaceutically acceptable salts, individual isomers or a racemic or non-racemic mixture, their pharmaceutical compositions and methods for their use as therapeutic agents are disclosed, wherein R1, R2, R3, R4 and R5 are as described in the specification.
Patent NZ-508253-A (NZ)
Title: Rheometer having twisted blade
Inventor: ILES CHRISTOPHER MARTIN
IPC: G01N33/00
Filed: 2000-11-17
Abstract: Rheometer blade 1 has inner region 4 aligned with rotational axis 2, and an outer region that is twisted so as not to align with this axis.
Patent NZ-509300-A (NZ)
Title: A gaming machine using rotatable dice as game symbols
Inventor: MUIR ROBERT LINLEY
IPC: G07F17/34
Filed: 2001-01-10
Abstract: A gaming machine includes: a control means for controlling operation of a game played on the gaming machine and a video display means on which a game played under the control of the control means is displayed.  The game is displayed on the display unit comprising a video simulation of a plurality of polyhedral elements.  Each of which has a plurality of faces with a predetermined indicium being carried on at least one face of each element.  The elements are displayed in a predetermined unchanging location relative to one another and the elements being rotatable, when the game is played, about at least one axis to bring certain faces into view.  The rest positions of the faces and the indicia are carried on visible faces of the polyhedral elements being amongst the determining conditions as to whether or not a winning result has been achieved in the game.
Patent NZ-511067-A (NZ)
Title: Serine protease inhibiting isoquinoline derivatives and their use for treating or preventing thrombin-mediated or thrombin-associated diseases
Inventor: TIMMERS CORNELIS MARIUS
IPC: A61P35/00
Filed: 1999-10-19
Abstract: A serine protease inhibitor of formula (I), wherein: J is H, R1, R1-SO2, R3OOC-(CHR2)p-, (R2a, R2b)N-CO-(CHR2)p- or Het-CO-(CHR2)p-; D is an amino-acid of the formula -NH-CHR1-C(O)-, -NR4- CH[(CH2)qC(O)OR1]-C(O)-, -NR4-CH[(CH2)qC(O)N(R2a,R2b)]-C(O)- , -NR4-CH[(CH2)qC(O)Het]-C(O)-, D-1,2,3,4- tetrahydroisoquinoline-1-carboxylic acid, D-1,2,3,4- tetrahydroisoquinoline-3-carboxylic acid, D-2- aminotetraline-2-carboxylic acid, 2-aminoindan-2-carboxylic acid, D-perhydroisoquinolyl 1-carboxylic acid or D- perhydroisoquinolyl 3-carboxylic acid; E is -N(3-6C)cycloalkyl-CH2- or the fragment of formula (a), optionally substituted with (1-6C)alkyl or (1- 6C)alkoxy; R1 is selected from (1-12C)alkyl, (3-12C)cycloalkyl and (3- 12C)cycloalkyl(1-6C)alkylene, which groups may optionally be substituted with (3-12C)cycloalkyl, (1-6C)alkoxy, oxo, and from (6-14C)aryl, (7-15C)aralkyl and (14- 20C)(bisaryl)alkyl, whereby the aryl group may optionally be substituted with (1-6C)alkyl, (3-12C)cycloalkyl, (1- 6C)alkoxy, OH, CF3 or halogen; R2 is H; R2a and R2b are each independently selected from H, (1- 8C)alkyl, (3-8C)cycloalkyl and (3-6C)cycloalkyl(1- 4C)alkylene, which can each be optionally substituted with (3-6C)cycloalkyl, (1-6C)alkoxy, and from (6-14C)aryl and (7- 15C)aralkyl whereby the aryl group may optionally be substituted with (1-6C)alkyl, (3-6C)cycloalkyl, (1- 6C)alkoxy, CF3 or halogen; R3 is H, (1-8C)alkyl, (3-8C)cycloalkyl or (3- 6C)cycloalkyl(1-4C)alkylene, which can each be optionally substituted with (3-6C)cycloalkyl, (1-6C)alkoxy, and from (7-15C)aralkyl whereby the aryl group may optionally be substituted with (1-6C)alkyl, (3-6C)cycloalkyl, (1- 6C)alkoxy, CF3 or halogen and form Het-(1-6C)alkyl; R4 is H or (1-3C)alkyl; X and Y are CH or N with the proviso that they are not both N; Het is a 4-, 5- or 6-membered heterocycle containing one or more heteroatoms selected from O, N and S; m is 1 or 2; p is 1, 2 or 3; q is 1, 2 or 3; t is 2, 3 or 4; or a N-alkoxycarbonyl protected derivative thereof; and/or a pharmaceutically acceptable addition salt and/or solvate thereof and its use in therapy and manufacture of a medicament for treating or preventing thrombin-mediated and thrombin-associated diseases is disclosed.
Patent NZ-513160-A (NZ)
Title: Graphite and ceramic material impregnated with a polymer and a metal or metal alloy
Inventor: VAZ GUY ANDREW
IPC: C23C2/00
Filed: 2001-07-25
Abstract: A method for forming a metal matrix composite material from woven or chopped graphite and a ceramic material, in which the following steps are employed: Impregnating the graphite with a polymer containing a metal powder; drying the graphite and finally passing the graphite through a molten bath of metal allow at a temperature to carbuise the polymer.
Patent NZ-514011-A (NZ)
Title: Method of treating eating disorders
Inventor: MENDEL CARL M
IPC: A61P1/14
Filed: 2000-03-17
Abstract: A compound of formula Ior a pharmaceutically acceptable salt thereof in which R1 and R2 are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for treating eating disorders, such as anorexia nervosa, bulimia nervosa, weight-gain after smoking cessation, snacking or binge eating.